Integral Diagnostics Limited
ITGDF
$0.98
-$1.05-51.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 495.16M | 448.43M | 404.42M | 363.09M | 324.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 495.16M | 448.43M | 404.42M | 363.09M | 324.08M |
| Cost of Revenue | 339.21M | 307.70M | 278.09M | 248.99M | 221.50M |
| Gross Profit | 155.96M | 140.72M | 126.34M | 114.09M | 102.58M |
| SG&A Expenses | 27.32M | 24.72M | 22.28M | 20.20M | 18.25M |
| Depreciation & Amortization | 45.11M | 40.66M | 36.47M | 33.81M | 31.36M |
| Other Operating Expenses | 19.84M | 18.44M | 17.15M | 15.30M | 13.55M |
| Total Operating Expenses | 449.52M | 407.08M | 367.15M | 330.33M | 295.60M |
| Operating Income | 45.64M | 41.35M | 37.28M | 32.76M | 28.47M |
| Income Before Tax | 16.29M | 11.83M | 7.40M | 6.63M | 5.94M |
| Income Tax Expenses | 7.10M | 5.72M | 4.35M | 3.26M | 2.21M |
| Earnings from Continuing Operations | 9.19 | 6.11 | 3.04 | 3.37 | 3.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -103.80K | -98.20K | -92.60K | -45.80K | -- |
| Net Income | 9.08M | 6.01M | 2.95M | 3.32M | 3.73M |
| EBIT | 45.64M | 41.35M | 37.28M | 32.76M | 28.47M |
| EBITDA | 68.85M | 61.97M | 55.46M | 49.86M | 44.57M |
| EPS Basic | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
| Normalized Basic EPS | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
| Normalized Diluted EPS | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 1.47B | 1.35B | 1.23B | 1.09B | 962.49M |
| Average Diluted Shares Outstanding | 1.50B | 1.37B | 1.24B | 1.10B | 962.49M |
| Dividend Per Share | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
| Payout Ratio | 155.10% | 199.57% | 338.91% | 269.92% | 214.43% |